Taigen Biotech

Could Covid Silently Benefit Us by Providing a Cure for Influenza?

The similarities found between SARS-CoV-2 and SARS-CoV, MERS-CoV, or human immunodeficiency viruses (HIV) can enhance the development of potential therapeutic…

4 years ago

TaiGen files US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral…

4 years ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More